Trial site selection is the subject of the next Oncology Center of Excellence “project” and could be a precursor to a more formal effort by the US Food and Drug Administration to improve clinical research diversity.
Project Site Selector will include discussions with industry about how trial sites are picked. OCE Director Richard Pazdur said the agency wants to gain a better understanding of the process,...